Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Monopar Therapeutics Inc
(NQ:
MNPR
)
14.67
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Monopar Therapeutics Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Is WiSA Technologies (WISA) Stock Down 22% Today?
March 28, 2023
WiSA Technologies (WISA) stock is falling on Tuesday but that's only after the company's shares underwent a rally yesterday.
Via
InvestorPlace
Why Is Monopar Therapeutics (MNPR) Stock Down 47% Today?
March 28, 2023
Monopar Therapeutics (MNPR) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 28, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 28, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!
Via
InvestorPlace
What's Going On With Monopar Therapeutics Shares Today?
February 14, 2023
Via
Benzinga
Monopar to Present at the Jefferies Radiopharma Innovation Summit
March 28, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Result of Interim Analysis of Phase 2b/3 VOICE Trial Evaluating Validive for Severe Oral Mucositis
March 27, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 23, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Thursday morning!
Via
InvestorPlace
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Developments
March 23, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 21, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 21, 2023
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 16, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 16, 2023
It's time for another dive into the biggest pre-market stock movers as we go over all the latest news for Thursday morning!
Via
InvestorPlace
Monopar to Present at the 35th Annual Roth Conference
March 07, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 02, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the latest news for Thursday morning!
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 28, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!
Via
InvestorPlace
Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket
February 27, 2023
Gainers Lucira Health, Inc. (NASDAQ: LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.
Via
Benzinga
Monopar and NorthStar Announce Expanded Radiopharma Program, Positive Preclinical Results, and Visibility Toward Human Trials
February 27, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 22, 2023
Via
Benzinga
Monopar Announces Camsirubicin Clinical Program Update - Improved Side Effect Profile Seen to Date Compared to Doxorubicin
February 14, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Projected Timeline of Upcoming Q1 2023 Data Events for Validive, Camsirubicin, and MNPR-101 RIT
January 26, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
January 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 20, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
January 20, 2023
It's the final day of trading this week and we're checking in on the biggest pre-market stock movers for Friday morning!
Via
InvestorPlace
Monopar Announces Successful Advancement of Camsirubicin Phase 1b Clinical Trial Past Fourth Cohort, Escalates Next to 650mg/m2
January 18, 2023
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 20, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday
December 20, 2022
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 15, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
December 15, 2022
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.